Semaglutide and tirzepatide are "upstream" they act on incretin receptors to influence appetite regulation, gastric emptying, and glucose-dependent insulin secretion
Use of GLP-1 drugs is already huge and is set to become even more common, as the medicines become cheaper, with more variations, including the recently launched , easier-to-use Wegovy pill from Novo Nordisk
Reducing Appetite Semaglutide acts on the brains appetite centers, specifically in the hypothalamus, to decrease hunger
See the CJC-1295 research overview
Glutathione peptide is not just for those with chronic health conditions
Conclusions Our retrospective cohort study of 571 patients with an ME/CFS diagnosis, without a co-diagnosis of fibromyalgia, suggests medications used by ME/CFS specialists are being underused by nonspecialists